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Site-specific Cell Proliferation in Renal Tubular
Cells by the Renal Tubular Carcinogen tris(2,3-
Dibromopropyl)phosphate
by Michael L. Cunningham,1 Michael R. Elwel,2 and H. B.
Matthews1
Our laboratory has been examining the mechanisms whereby chemicals are mutagenic in
short-term in-vitro assays yet are not carcinogenic in 2-year rodent bioassays. Previous studies
indicated that mutagenic carcinogens increased the amount of cell turnover in the target
organ, but that mutagenic noncarcinogens failed to do so. The present study compares the inci-
dence ofcell proliferation in specific regions ofthe kidney, which is the site ofcarcinogenicity,
with cell proliferation induced in a nontarget tissue, the liver, by the mutagenic renal tubular
carcinogen tris(2,3-dibromopropyl)phosphate (TRIS). Renal tubular adenocarcinoma induced
by TRIS was the only tumor type identified in male F344 rats, and it was localized in the outer
medulla. Male F344 rats were fed a diet containing 0, 50, or 100 ppm TRIS for 14 days. These
doses were identical to the doses given in the National Toxicology Program cancer bioassay.
Replicating cells were labeled with bromodeoxyuridine administered by an osmotic minipump
and identified in tissue sections from liver and kidney using immunohistochemical techniques.
Examination ofliver sections showed no chemically related increases in cell proliferation above
control for either dose group. However, in the kidney, TRIS induced significant cell prolifera-
tion that was localized in the renal outer medulla region, the target area for carcinogenesis.
The labeling index (number of labeled cells/total number of cells counted) in the kidneys of
TRIS-exposed rats was increased approximately 4-fold in the outer medulla and was not
increased in the cortex or inner medulla. The results of this study suggest an association
between the chemically-induced renal cell proliferation and the renal carcinogenicity ofTRIS.
Introduction
Recent reports (1,2) have demonstrated that
although there is a high degree of association between
mutagenesis in Salmonella and carcinogenicity in
rodents, there are also a large number of carcinogens
whose actions are not explained by mutagenicity and
structural alert data. Our studies center on mutagenic
noncarcinogens and describe comparisons with muta-
genic carcinogens in an effort to discover the mecha-
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nism(s) whereby the carcinogens act to produce
tumors that are missing in the effect ofthe noncarcino-
gens. The mutagenic noncarcinogens are the class of
chemicals referred to as "false-positives," chemicals
that produce mutagenicity in short-term assays and
possess structural alerts (3), which would, therefore,
be predicted to be carcinogenic, yet are noncarcino-
genic in rodents. Results presented here represent a
continued effort to determine the sources of these
apparently discordant results and are of value in
understanding the differences between in vitro and in
vivo systems for the evaluation of chemical carcino-
genicity or lack thereof.
Our previous results indicate that the carcinogenici-
ty of a chemical may be related not only to its DNA-
damaging capability as measured by its activity in
mutagenicity tests, but also to its ability to cause an
increase in cell division in animals (4,5). The flame
retardant tris(2,3-dibromopropyl)phosphate (TRIS;
Fig. 1) was studied to examine the cell proliferative
effects of a mutagenic renal carcinogen. TRIS is muta-
genic in the Ames/Salmonella assay, in the presence ofCUNNINGHAM ETAL.
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FIGURE 1. Structure of the mutagenic renal carcinogen tris(2,3-
dibromopropyl) phosphate. The underlined group is identified as a
structural alert for carcinogenicity as described by Ashby and
Tennant (3).
metabolic activation (6). TRIS was demonstrated to be
a potent renal carcinogen in male and female F344 rats
and male B6C3F1 mice (7). A closer examination ofthe
lesions indicated that TRIS caused renal tubular ade-
noma and adenocarcinoma primarily in the outer
medulla. Results of the present study provide further




Male Fischer F344 rats (Charles River Breeding
Laboratories, Raleigh, NC) weighing 150 g were main-
tained on a standard NIH 31 diet ad libitum and a daily
cycle ofalternating 12-hr periods oflight and darkness.
The animals were acclimated to this environment for 2
weeks before the experiment began and were main-
tained at 21-23°C and at 40-60% relative humidity.
Rats were randomly assigned to treatment groups of5
animals per group and allowed 24 hr to adapt to a new
cage environment and the powdered chow mixture
(without chemical), described below. Experiments
were performed according to the guidelines estab-
lished in the NIH Guide for the Care and Use of
Laboratory Animals.
Chemical Treatment
Wy-14,643, a potent hepatocarcinogen, was used in
this study as a positive control for increased hepatic
cell proliferation. Wy-14,643 was purchased from
Chemsyn Science Laboratories (Lenexa, KS). TRIS
was obtained from the National Toxicology Program
NTP) repository. Chemicals were dissolved in acetone
(100 ,L) and added to a mixture of powdered NIH 31
chow (20 g/rat) and agar (2 g/rat), followed by addition
of warm water (60 mL/rat). The final concentration of
Wy-14,643 was 100 ppm and TRIS was 50 or 100 ppm.
This mixture was a moist solid and was very palatable
to the rats. It was prepared daily for each animal and
was their sole source of food during the experiment.
Control animals received this powdered chow mixture
with 100 ,uL acetone. Animals were killed 1 day after
the final dose.
Cell Proliferation Measurements
The animals were allowed to adjust to chemical
treatment for 1 day. Osmotic minipumps (Alza Cor-
poration, Palo Alto, CA, model 2002) were then
implanted subcutaneously into the backs of the rats.
These minipumps delivered bromodeoxyuridine (BrdU)
(Sigma Chemical Co., St. Louis, MO) at 30 ,ug/hr for 2
weeks. BrdU is incorporated into the DNA ofreplicat-
ing cells. Fourteen days later, the animals were eutha-
nized by CO2 inhalation, livers were weighed, and mid-
lobe radial sections of the right anterior lobe were
fixed in 70% cold ethanol for 24 hr. The mid-lobe radial
section was chosen to avoid possible interlobe varia-
tion in BrdU incorporation. A cross-section of small
intestine was also fixed as a positive control for the
proper operation of the minipump and the staining
technique. Tissues were embedded in paraffin, stained
with hematoxylin and eosin for histological analysis,
and stained immunohistochemically for BrdU incorpo-
ration as described previously (4,5). Random areas of
the slides were chosen for counting stained and
unstained hepatocyte nuclei (>1000 hepatocytes/ rat).
Because Wy-14,643 produced an uneven distribution
of labeling across the lobule, the labeling index includ-
ed labeled and unlabeled hepatocytes in periportal,
mridzonal, and centrilobular areas (approximately 350
hepatocytes per area). Three counts from each area
were made from each animal. Statistics were per-
formed using the Student's t-test and summed for com-
parison to the vehicle-treated control. Kidneys in some
experiments were perfused briefly with sodium phos-
phate buffer (pH 7.4) followed by 2% paraformalde-
hyde-1% glutaraldehyde (8). This allowed for analysis
of cell proliferation in specific segments. Our prelimi-
nary results indicated that there was no difference in
labeling between P1, P2, or P3 segments. Therefore,
kidneys were transected into 2-mm sections (median
transverse) and drop fixed in 10% neutral buffered for-
malin for 24 hr, followed by paraffin embedding and
sectioning at 2 jum, followed by immunohistochemical
staining as described. Quantitation of cell proliferation
was performed as described by Short et al. (8), except
that quantitation of labeling in specific segments was
not necessary.
Results
Rats exposed to TRIS showed no changes in
liver/body weight ratios compared to vehicle-treated
animals. The positive control, Wy-14,643 showed a sta-
tistically significant increase in this ratio (Table 1).
Hepatocyte proliferation, as measured by BrdU incor-
poration in livers of rats treated with TRIS, was not
statistically different from vehicle-treated animals
(Table 2). Cell proliferation in the livers of animals
exposed to dietary Wy-14,643 showed an approximate-
ly 13-fold increase in cell proliferation during the
course of the 2-week exposure period (Table 2).
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Table 1. Weight gain and liver/body weight ratios for male
F344 rats after dietary exposure to tris(2,3-dibromo-
propyl)phosphate (TRIS) or Wy-14,643 for 14 days.
Body weight Liver weight/
Treatment gain, g body weight
Vehicle (acetone) 9.0 ± 7 0.044 ± 0.004
Wy-14,643, 100 ppm 0.6 ± 9 0.076 ± 0.004*
TRIS
50 ppm 12.4 ± 1 0.049 ± 0.001
100 ppm 11.7 ±1 0.046 ± 0.001
*p < 0.01 compared to vehicle control; n = 5.
Table 2. Bromodeoxyuridine labeling indexes ofhepato-
cytes in male F344 rats after dietary exposure to tris(2,3-
dibromopropyl)phosphate (TRIS) or Wy-14,643 for 14 days.
Labelingindex, Fold increase
Treatment %a over control
Vehicle (acetone) 3.4 ± 1.3
Wy-14,643, 100 ppm 65 ±12 19*
TRIS
50 ppm 3.0 ± 1.0 0.9
100 ppm 2.8 ± 0.3 0.8
aNumber ofhepatocytes staining positive for bromodeoxyuridine/
1000 hepatocytes x 100%
bAverage ofcounts from periportal, midzonal, and centrilobular
areas.
*p < 0.001 compared to vehicle control; n = 5.
Because Wy-14,643 induces primarily a periportal pat-
tern of cell proliferation by this exposure regimen,
measurements from both periportal and centrilobular
areas were averaged. The only group demonstrating
microscopic changes was the Wy-14,643 group. Livers
of rats in this treatment group exhibited slightly
enlarged hepatocytes compared to controls, and the
cytoplasm was more eosinophilic, with a fine granular
appearance.
Only kidneys from animals treated with TRIS
showed increased cell proliferation (Table 3; Figure 2).
The 14-day exposure to 50 ppm TRIS increased the
labeling index in the outer medulla 4.0-fold above the
control value. Labeling indexes in the cortex of inner
medulla were not significantly affected, nor were there
increases in the labeling indexes of rats treated with
Wy-14,643. Increased cell proliferation in the outer
medulla was also observed in the high-dose group (100
ppm), but it did not appear to be dose related (Table 3).
No other microscopic changes were observed in the
kidneys of either the Wy-14,643 or the TRIS-treated
animals.
Discussion
Cell proliferation is known to be an important com-
ponent in the induction of chemical carcinogenesis in
multistage rodent carcinogenesis models (9). Recent
studies have demonstrated a strong correlation
between chemically induced cell proliferation and car-
Table 3. Bromodeoxyuridine labeling indexes in kidneys of
male F344 rats after dietary exposure to tris(2,3-dibromo-




Cortex 4.3 ± 0.5
Outer medulla 8.7 ± 0.9
Inner medulla 4.7 ± 1.6
TRIS, 50 ppm
Cortex 7.7 ± 2.8 1.8
Outer medulla 34.7 ± 5.9* 4.0*
Inner medulla 5.5 ± 1.6 1.2
TRIS, 100 ppm
Cortex 8.0 ± 2.1 1.9
Outer medulla 23.1 ± 1.9* 2.7*
Innermedulla 4.9 ± 1.4 1.1
aNumber oflabeled renal tubular cells/total number oflabeled plus
unlabeled cells x 100%.
*p < 0.02compared to vehicle control.
cinogenesis by a variety of genotoxic (4,5) and non-
genotoxic compounds (10). Although the exact role of
induced cell proliferation in carcinogenesis is not cer-
tain (11), increasing the rates ofcell division, either by
mitogenesis or compensatory hyperplasia secondary to
cell killing, may prevent the repair of spontaneously
occurring mutations (12) or activate protooncogenes
(13). Data in this report support our earlier specula-
tion that chronic, chemically induced toxicity and
resulting cell proliferation may play a role in carcino-
genesis induced by mutagenic chemicals.
The observation that TRIS induced cell proliferation
only in the outer medulla ofthe kidney prompted a fur-
ther review ofthe slides ofthe TRIS bioassay. Results
of this evaluation indicated that renal adenomas and
adenocarcinomas were found almost exclusively in the
outer medulla after 2-year feeding studies and provide
strong evidence for the role of cell proliferation in the
renal carcinogenesis induced by TRIS. The observa-
tion that cell proliferation may be tissue or cell-type
specific may, therefore, be of predictive value. Infor-
mation on the mutagenicity ofa chemical, in addition to
data on the site of induction of cell proliferation, may
prove useful for the prediction of carcinogenicity and
its localization within a tissue or organ. The observa-
tion that the dose-response relationship for cell prolif-
eration in this study and the incidence ofrenal tubular
carcinogenesis were both flat is very interesting. This
suggests that at 50 ppm, a maximal effect occurred in
both studies. This may have resulted from saturated
absorption or metabolism of TRIS, and preliminary
(unpublished) data indicate that it is a gender-related
phenomenon. Further studies are being conducted on
the toxicokinetics of TRIS to more fully explain this
observation.
The experimental design in this study was intended






FIGURE 2. Photomicrographs ofrenal medulla stained with anti-bromodeoxyuridine antibody and ABC immunocytochemistry after (A) vehicle
or (B) tris(2,3-dibromopropyl)phosphate (50 ppm) for 14 days in the diet. Hematoxylin counterstain, 40X.
cell replication. It was not intended to answer the
question of the sustainability of the induced cell repli-
cation. Transient bursts ofcell proliferation, up to sev-
eral weeks, may be sufficient to produce the conditions
favorable to but may not be sufficient for induction of
carcinogenesis (14). This may be especially true for
mutagenic chemicals, and the combination of muta-
genicity and at least a transient round of cell replica-
tion may enhance the induction of carcinogenesis (4).
In support of this concept, it was observed that the
first identifiable step in diethylnitrosamine hepatocar-
cinogenesis is the appearance ofaltered foci containing
glutathione transferase-placental form (GST-P+),
which was demonstrated to occur in the same hepato-
cytes that stain positive for BrdU (15). These data sug-
gest that induced cell proliferation may act in the initi-
ation stage of chemical carcinogenesis, at least for
mutagenic chemicals, as has been observed earlier (9).
Nonmutagenic carcinogens, such as Wy-14,643, may
require more sustained levels of cell proliferation to
induce carcinogenesis than are required for mutagenic
carcinogens (14). Clearly, more research is needed to
evaluate the relevance of transient versus sustained
cell proliferation in the carcinogenicity of mutagenic
and nonmutagenic chemicals.
Cell proliferation data may become routine in the
evaluation of chemical toxicity, and we are incorporat-
ing the evaluation ofcell proliferation into many ofthe
NTP toxicity studies. As the relationship of cell prolif-
eration and carcinogenesis appears to be tissue, cell
type, and possibly species and gender specific, extrap-
olation ofthese effects will require additional research.
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